Ilaris 150 mg/mL injection Images

Generic Name: canakinumab

This medication has been identified as Ilaris 150 mg/mL injection. It is supplied by Novartis Pharmaceuticals Corporation.

Ilaris is used in the treatment of Cryopyrin-Associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Familial Mediterranean Fever; Gout, Acute; Hyperimmunoglobulin D Syndrome and belongs to the drug class interleukin inhibitors. Risk cannot be ruled out during pregnancy. Ilaris 150 mg/mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Ilaris

Generic Name

canakinumab

Strength

150 mg/mL injection

Availability

Prescription only

Drug Class

Interleukin inhibitors

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Novartis Pharmaceuticals Corporation

National Drug Code (NDC)

00078-0734

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer